HealthCanadaWambaugh03115-draft.pptx (13.73 MB)
Download fileExposure and Dosimetry Considerations for Adverse Outcome Pathways
presentation
posted on 2017-06-30, 13:51 authored by John Wambaugh, 0000-0002-4024-534XPresented at the Application of New Methods in Risk Science in Regulatory Decision-Making Regarding
Chemical Substances